Detalles de la búsqueda
1.
Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome.
Br J Haematol
; 200(3): 306-314, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36261137
2.
Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma.
Br J Haematol
; 196(3): 589-598, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34632572
3.
Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab era.
Eur J Haematol
; 104(5): 400-408, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31804029
4.
Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era.
Br J Haematol
; 184(5): 753-759, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30515755
5.
Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of ß2 -microglobulin yields a more accurate GELTAMO-IPI.
Br J Haematol
; 176(6): 918-928, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28106247
6.
HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma.
Mod Pathol
; 30(5): 745-760, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28084335
7.
Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
Ann Hematol
; 96(3): 405-410, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28035434
8.
Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy.
Ann Hematol
; 94(5): 803-12, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25501975
9.
In vivo intratumoral Epstein-Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications.
Mod Pathol
; 27(12): 1599-611, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24762547
10.
MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
Haematologica
; 98(10): 1554-62, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23716551
11.
Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma.
Eur J Nucl Med Mol Imaging
; 40(4): 496-504, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23344136
12.
Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study.
Clin Cancer Res
; 27(2): 513-521, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33122345
13.
T-cell subsets in lymph nodes identify a subgroup of follicular lymphoma patients with favorable outcome.
Leuk Lymphoma
; 58(4): 842-850, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27687692
14.
High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma.
Leuk Res
; 59: 20-25, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28544905
15.
MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome.
Clin Cancer Res
; 22(11): 2755-64, 2016 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26792260
16.
Fatal immune hemolytic anemia following allogeneic stem cell transplantation: report of 2 cases and review of literature.
Transfus Med Rev
; 27(3): 166-70, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23562007
Resultados
1 -
16
de 16
1
Próxima >
>>